The Global Infectious Diseases & One Health Conference (GIOH-2026) is delighted to welcome Dr. Eric I. Tsao, CEO of Synermore Biologics, China, as a distinguished speaker.
Conference Details
·
Conference: Global Infectious Diseases
& One Health Conference (GIOH-2026)
·
Dates: September 21–23, 2026
·
Venue: London, United Kingdom &
Online
Speaker Profile
Dr. Eric
I Tsao has served as the Chief Executive Officer of Synermore Biologics
since founding the company in 2013. With more than 25 years of experience in
the biopharmaceutical industry, he has held leadership positions at Johnson
& Johnson, AstraZeneca, and Morningside Group. His expertise includes
biological product development, process design, facility engineering, and
manufacturing operations. Dr. Tsao earned his Ph.D. in Chemical Engineering
from the University of Michigan.
Presentation
Oral Presentation (In-Person)
Title: SYN023 mAb cocktail for
rabies prophylaxis
Dr. Tsao will present insights into the development of SYN023, a monoclonal
antibody cocktail designed for rabies prophylaxis. His session will explore
innovative biologics and their role in advancing infectious disease prevention.
Join GIOH-2026 to connect with leading researchers, clinicians, healthcare
professionals, and industry experts dedicated to addressing global infectious
disease challenges through the One Health approach.
#GIOH2026 #EricITsao #SynermoreBiologics #Rabies #SYN023 #InfectiousDiseases #OneHealth
No comments:
Post a Comment